Search research articles
Contact Us
Filters
Showing results (291-300 of 386) with videos related to
Page
of 39
Sort By:
Archives of Pathology & Laboratory Medicine
|
December 31, 2015
Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial
John M S Bartlett, Jason Christiansen, Mark Gustavson, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Expression of activated type I receptor tyrosine kinases in early breast cancer
Melanie Spears, Hans Christian Pederson, Nicola Lyttle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2022
Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study
John M S Bartlett, Dennis C Sgroi, Kai Treuner, et al.
Molecular Cancer
|
February 16, 2011
Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer
Sampoorna Satheesha, Victoria J Cookson, Louise J Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Multidisciplinary meeting on male breast cancer: summary and research recommendations
Larissa A Korde, Jo Anne Zujewski, Leah Kamin, et al.
Journal of Clinical Microbiology
|
March 21, 1998
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes
C H Lee, J Helweg-Larsen, X Tang, et al.
British Journal of Cancer
|
August 2, 2006
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies
P de Graeff, J Hall, A P G Crijns, et al.
JCO Precision Oncology
|
February 1, 2022
Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers
Jane Bayani, Elizabeth N Kornaga, Cheryl Crozier, et al.
Breast Cancer Research and Treatment
|
March 11, 2011
The p160 ER co-regulators predict outcome in ER negative breast cancer
Melanie Spears, Steffi Oesterreich, Ilenia Migliaccio, et al.
Breast Cancer Research : BCR
|
October 7, 2025
Genomic landscape of cancer driver genes in Omani breast cancers: a pilot study
Muna Al Dlali, Buthaina Al Amri, Noura Al Zeheimi, et al.
Page
of 39
Search research articles
Search
Showing results (291-300 of 386) with videos related to
Sort By:
Page
of 39
Archives of Pathology & Laboratory Medicine
|
December 31, 2015
Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial
John M S Bartlett, Jason Christiansen, Mark Gustavson, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Expression of activated type I receptor tyrosine kinases in early breast cancer
Melanie Spears, Hans Christian Pederson, Nicola Lyttle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2022
Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study
John M S Bartlett, Dennis C Sgroi, Kai Treuner, et al.
Molecular Cancer
|
February 16, 2011
Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer
Sampoorna Satheesha, Victoria J Cookson, Louise J Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Multidisciplinary meeting on male breast cancer: summary and research recommendations
Larissa A Korde, Jo Anne Zujewski, Leah Kamin, et al.
Journal of Clinical Microbiology
|
March 21, 1998
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes
C H Lee, J Helweg-Larsen, X Tang, et al.
British Journal of Cancer
|
August 2, 2006
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies
P de Graeff, J Hall, A P G Crijns, et al.
JCO Precision Oncology
|
February 1, 2022
Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers
Jane Bayani, Elizabeth N Kornaga, Cheryl Crozier, et al.
Breast Cancer Research and Treatment
|
March 11, 2011
The p160 ER co-regulators predict outcome in ER negative breast cancer
Melanie Spears, Steffi Oesterreich, Ilenia Migliaccio, et al.
Breast Cancer Research : BCR
|
October 7, 2025
Genomic landscape of cancer driver genes in Omani breast cancers: a pilot study
Muna Al Dlali, Buthaina Al Amri, Noura Al Zeheimi, et al.
Page
of 39